Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - japanese encephalitis virus, quantity: 6 agu - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; sodium chloride; monobasic potassium phosphate; dibasic sodium phosphate; water for injections - jespect is indicated for active immunisation against japanese encephalitis (je) virus for persons 18 years of age and older. jespect should be considered for use in persons who plan to reside in or travel to areas where je is endemic (common) or epidemic (seasonal), especially during the transmission season. jespect is indicated for persons who work with je virus in laboratories and in industry.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - lespedeza - to relieve the symptoms of anxiety. indications: lespedeza   anxiety if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - lespedeza - to relieve the symptoms of anxiety. indications:  lespedeza   anxiety if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

vifiteh cjsc - lespedeza bicolor - solution oral - 708mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

vifiteh cjsc - lespedeza bicolor - solution oral - 708mg/ml

United States - English - NLM (National Library of Medicine)

respected roots, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. - on children less than 2 months of age - on open skin wounds stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - japanese encephalitis vaccine 6 units - suspension for injection - 6 u/dose - active: japanese encephalitis vaccine 6 units excipient: aluminium hydroxide gel dibasic sodium phosphate monobasic potassium phosphate sodium chloride - jespect® is indicated for active immunisation against japanese encephalitis (je) virus for persons 18 years of age and older. jespect® should be considered for use in persons who plan to reside in or travel to areas where je is endemic (common) or epidemic (seasonal), especially during the transmission season. jespect® is indicated for persons who work with je virus in laboratories and in industry.

United States - English - NLM (National Library of Medicine)

novo nordisk - antihemophilic factor, human recombinant (unii: p89dr4ny54) (antihemophilic factor, human recombinant - unii:p89dr4ny54) - esperoct [antihemophilic factor (recombinant), glycopegylated-exei] is a recombinant dna-derived coagulation factor viii concentrate indicated for use in adults and children with hemophilia a for: limitation of use: esperoct is not indicated for the treatment of von willebrand disease. (1) esperoct is contraindicated in patients who have known hypersensitivity to esperoct or its components (including hamster proteins) [see warnings and precautions (5.1) and description (11) ]. there are no data with esperoct use in pregnant women to determine whether there is a drug-associated risk. animal reproduction studies have not been conducted with esperoct. it is unknown whether esperoct can cause fetal harm when administered to a pregnant woman or can affect fertility. in the u.s. general population, the estimated background risk of major birth defect and miscarriage in clinically recognized pregnancies is 2–4% and 15–20%, respectively. risk summary there is no information regarding the presence of esperoct in human

Israel - English - Ministry of Health

novo nordisk ltd., israel - turoctocog alfa pegol - powder and solvent for solution for injection - turoctocog alfa pegol 1000 iu/vial - treatment and prophylaxis of bleeding in previously treated patients with haemophilia a (congenital factor viii disorder).esperoct® does not contain pharmacologically active quantities of von willebrand factor and is, therefore, unsuitable for the treatment of von willebrand disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

millenium pharmaceuticals pty ltd - hesperidin, quantity: 112.5 mg/g; iron, quantity: 1.25 mg/g; selenium, quantity: 2.5 mg/g; zinc, quantity: 1.25 mg/g; calcium ascorbate dihydrate, quantity: 176 mg/g (equivalent: ascorbic acid, qty 145.5 mg/g); ascorbic acid, quantity: 350 mg/g; manganese, quantity: 1.25 mg/g - powder, oral - excipient ingredients: glucose monohydrate; riboflavin sodium phosphate; stevia rebaudiana; colloidal anhydrous silica; flavour - antioxidant/reduce free radicals formed in the body ; helps enhance/promote general health and wellbeing ; helps enhance/improve/promote blood circulation to the peripheral areas of the body (legs, hands and feet) ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; decrease/reduce/relieve symptoms of hayfever ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms